Search - tctmd.com

Displaying 341 - 360 of 1672

Sort: Relevancy | Date

Presentation TCT 2024

TRILUMINATE Pivotal Trial: Outcomes in the Primary Analysis Population vs Subsequent Enrollment

Presenter: Gilbert Tang

October 27, 2024

Presentation TCT 2024

Transcatheter Leaflet Repair for Tricuspid Regurgitation: 1-Year Results From the PASTE Registry

Presenter: Mirjam Wild

October 27, 2024

Presentation TCT 2024

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the EuroTR Registry

Presenter: Lukas Stolz

October 27, 2024

Presentation ESC 2024

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Presenter: Erwan Donal

August 31, 2024

Presentation NY Valves 2024

Anatomy for Tricuspid Interventions: "Live" from the OR

Presenter: Isaac George

June 07, 2024

Presentation NY Valves 2024

What’s Next? Managing the Disease and Advanced Training

Presenter: Charles J. Davidson

June 07, 2024

Presentation NY Valves 2024

Why We Need a "Toolbox" Approach for the Tricuspid Valve

Presenter: Georg Nickenig

June 07, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Presenter: Brian K. Whisenant

June 07, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

Presenter: Susheel K. Kodali

June 07, 2024

Presentation NY Valves 2024

The Compelling Case for Transcatheter Tricuspid Therapies

Presenter: Philipp Lurz

June 07, 2024

Presentation NY Valves 2024

Case-in-Box - TOPAZ Transcatheter Tricuspid Valve Replacement

Presenter: Jörg Hausleiter

June 07, 2024

Presentation NY Valves 2024

What Is the Future of Percutaneous Tricuspid Valve Procedures?

Presenter: Eric Horlick

June 07, 2024

Presentation NY Valves 2024

Case-in-Box - Cardiovalve

Presenter: Christian Frerker

June 07, 2024

Presentation NY Valves 2024

Tricuspid Valve Anatomy (and Pathology): Who Is a Candidate for Transcatheter Tricuspid Valve Edge-to-Edge Repair?

Presenter: D. Scott Lim

June 07, 2024

Presentation NY Valves 2024

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Presenter: Michael I. Brener

June 07, 2024

Presentation NY Valves 2024

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

Presenter: Azeem Latib

June 07, 2024

Presentation NY Valves 2024

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

Presenter: Rishi Puri

June 07, 2024

Presentation NY Valves 2024

Anywhere But There: CIED Options (PPM/ICD) in Patients Following Tricuspid Valve Intervention

Presenter: Christopher Liu

June 07, 2024

Presentation NY Valves 2024

Walking the Tightrope: Bleeding vs Thrombosis Risk Following Transcatheter Tricuspid Valve Replacement

Presenter: Neil P. Fam

June 07, 2024

Presentation NY Valves 2024

RV Function and the Pulmonary Circulation: Physiological Insights Influencing Clinical Decision Making in TR Treatment

Presenter: Karl-Philipp Rommel

June 07, 2024

Advertisement

TRILUMINATE Pivotal Trial: Outcomes in the Primary Analysis Population vs Subsequent Enrollment

Transcatheter Leaflet Repair for Tricuspid Regurgitation: 1-Year Results From the PASTE Registry

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the EuroTR Registry

Multicentric randomized evaluation of a Tricuspid valve Percutaneous Repair System (T-TEER) in the treatment of severe Tricuspid Regurgitation TRI.Fr

Anatomy for Tricuspid Interventions: "Live" from the OR

What’s Next? Managing the Disease and Advanced Training

Why We Need a "Toolbox" Approach for the Tricuspid Valve

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

The Compelling Case for Transcatheter Tricuspid Therapies

Case-in-Box - TOPAZ Transcatheter Tricuspid Valve Replacement

What Is the Future of Percutaneous Tricuspid Valve Procedures?

Case-in-Box - Cardiovalve

Tricuspid Valve Anatomy (and Pathology): Who Is a Candidate for Transcatheter Tricuspid Valve Edge-to-Edge Repair?

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

Anywhere But There: CIED Options (PPM/ICD) in Patients Following Tricuspid Valve Intervention

Walking the Tightrope: Bleeding vs Thrombosis Risk Following Transcatheter Tricuspid Valve Replacement

RV Function and the Pulmonary Circulation: Physiological Insights Influencing Clinical Decision Making in TR Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content